Due to its ability to inhibit the sodium-activated potassium channel encoded by a potassium sodium-activated channel subfamily T member 1 (KCNT1) gene, QND has been used in epilepsy of infancy with migrating focal seizures (EIMFS) (#608167) caused by KCNT1 genetic variants [2]. Here, KCNT1 is linked to epilepsy.